Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
le Roux et al
The Bridge is a major shift in access for Medicare beneficiaries who would otherwise be priced out
This analysis uses 2023 Medicare claims for traditional Medicare, Medicare Advantage encounter data, and Part D prescription drug event data to estimate the total number of Medicare beneficiaries with obesity or overweight, the number of Part D enrollees who met the Bridge eligibility criteria in 2023, and those who met the Bridge clinical criteria but who also had diagnoses recorded in claims or encounter data that would qualify for Part D coverage of GLP-1s (type 2 diabetes, OSA, or MASH) or who had a GLP-1 Part D-covered prescription during the year, either of which would make them ineligible for Bridge (see Methods)
Em lares de renda mais alta, a reduo foi ainda maior, chegando a 9%
US$ 27.27
US$ 22.98
US$ 24.07
US$ 26.11
